Tobramycin is an active pharmaceutical ingredient used as an aminoglycoside antibiotic. It is noted for potential developmental toxicity based on government labeling requirements.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 32986-56-4
Kanamycin A
pharmaceutical raw material
Canamycin A disulfate
pharmaceutical raw material
Kanamycin sulfate
pharmaceutical raw material
Peramivir
pharmaceutical raw material
Paclitaxel
pharmaceutical raw material
Avanafil
pharmaceutical raw material
Vardenafil hydrochloride trihydrate
pharmaceutical raw material
Tobramycin sulfate
pharmaceutical raw material
(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol
NLVFBUXFDBBNBW-PBSUHMDJSA-N
C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N